US Stock MarketDetailed Quotes

Jin Medical International (ZJYL)

Watchlist
  • 2.200
  • -0.100-4.35%
Close May 7 16:00 ET
17.22MMarket Cap11.00P/E (TTM)

Jin Medical International (ZJYL) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(FY)Sep 30, 2024
(FY)Sep 30, 2023
(FY)Sep 30, 2022
(FY)Sep 30, 2021
(FY)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
340.50%2.9M
-138.87%-1.21M
96.53%3.11M
-72.95%1.58M
133.43%5.84M
2.5M
Net income from continuing operations
-59.61%1.38M
18.82%3.42M
6.34%2.88M
2.84%2.71M
19.30%2.63M
--2.21M
Operating gains losses
74.52%-10.81K
-518.64%-42.41K
---6.86K
----
3,741.09%13.37K
--348
Depreciation and amortization
1.31%350.68K
53.22%346.13K
-37.70%225.9K
4.61%362.6K
5.06%346.61K
--329.91K
Deferred tax
-160.74%-22.07K
-59.46%36.33K
204.16%89.6K
-5,072.76%-86.02K
97.87%-1.66K
---77.92K
Change In working capital
122.27%1.1M
-2,349.91%-4.92M
85.97%-200.81K
-148.33%-1.43M
8,597.76%2.96M
---34.86K
-Change in receivables
158.21%2.27M
-939.01%-3.91M
-212.71%-376.08K
-89.16%333.66K
173.60%3.08M
--1.12M
-Change in inventory
109.54%168.3K
-94.84%80.32K
408.38%1.56M
-209.98%-504.39K
133.45%458.61K
---1.37M
-Change in prepaid assets
43.43%-770.93K
-90.22%-1.36M
-266.31%-716.36K
154.36%430.74K
-4,642.58%-792.44K
---16.71K
-Change in payables and accrued expense
-162.41%-260.66K
161.06%417.66K
26.92%-684.07K
-117.80%-936.03K
-233.18%-429.77K
--322.7K
-Change in other current liabilities
-72.13%-144.13K
---83.73K
--0
--0
----
----
-Change in other working capital
-168.72%-171.32K
-414.77%-63.76K
102.68%20.26K
-216.60%-755.37K
785.46%647.86K
---94.51K
Cash from discontinued investing activities
Operating cash flow
340.50%2.9M
-138.87%-1.21M
96.53%3.11M
-72.95%1.58M
133.43%5.84M
--2.5M
Investing cash flow
Cash flow from continuing investing activities
-13.43%-10.79M
-23.08%-9.51M
-6,293.71%-7.73M
88.68%-120.9K
45.49%-1.07M
-1.96M
Net PPE purchase and sale
-4,484.59%-6.63M
-39.31%-144.6K
-158.43%-103.8K
6.33%-40.17K
69.83%-42.88K
---142.11K
Net intangibles purchase and sale
--0
---979.28K
--0
--0
----
----
Net business purchase and sale
---500K
--0
--0
----
----
----
Net investment purchase and sale
56.35%-3.66M
-10.01%-8.39M
-1,613.17%-7.63M
45.02%-445.17K
-383.72%-809.73K
--285.4K
Net other investing changes
----
----
----
269.48%364.43K
89.77%-215.03K
---2.1M
Cash from discontinued investing activities
Investing cash flow
-13.43%-10.79M
-23.08%-9.51M
-6,293.71%-7.73M
88.68%-120.9K
45.49%-1.07M
---1.96M
Financing cash flow
Cash flow from continuing financing activities
-36.91%7.35M
68.64%11.65M
5,571.18%6.91M
104.25%121.86K
-734.59%-2.87M
-343.91K
Net issuance payments of debt
10.55%7.59M
61.42%6.87M
--4.25M
--0
-678.54%-2.77M
---355.32K
Net common stock issuance
--0
-96.10%312K
--8M
--0
--0
----
Proceeds from stock option exercised by employees
--0
--0
--336.64K
--0
--0
----
Net other financing activities
-105.31%-237.88K
178.80%4.48M
-4,761.29%-5.68M
217.30%121.86K
-1,009.98%-103.88K
--11.42K
Cash from discontinued financing activities
Financing cash flow
-36.91%7.35M
68.64%11.65M
5,571.18%6.91M
104.25%121.86K
-734.59%-2.87M
---343.91K
Net cash flow
Beginning cash position
17.41%8.14M
44.59%6.93M
30.51%4.79M
120.75%3.67M
-14.34%1.66M
--1.94M
Current changes in cash
-157.33%-534.91K
-59.20%933.05K
44.59%2.29M
-16.99%1.58M
849.08%1.91M
--200.77K
Effect of exchange rate changes
-151.03%-139.64K
282.54%273.63K
67.50%-149.9K
-546.49%-461.24K
121.56%103.3K
---479.21K
End cash Position
-8.29%7.46M
17.41%8.14M
44.59%6.93M
30.51%4.79M
120.75%3.67M
--1.66M
Free cash flow
-59.82%-3.73M
-177.91%-2.33M
94.25%2.99M
-73.44%1.54M
145.69%5.8M
--2.36M
Currency Unit
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
Unqualified Opinion with Explanatory Notes
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Sep 30, 2025(FY)Sep 30, 2024(FY)Sep 30, 2023(FY)Sep 30, 2022(FY)Sep 30, 2021(FY)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 340.50%2.9M-138.87%-1.21M96.53%3.11M-72.95%1.58M133.43%5.84M2.5M
Net income from continuing operations -59.61%1.38M18.82%3.42M6.34%2.88M2.84%2.71M19.30%2.63M--2.21M
Operating gains losses 74.52%-10.81K-518.64%-42.41K---6.86K----3,741.09%13.37K--348
Depreciation and amortization 1.31%350.68K53.22%346.13K-37.70%225.9K4.61%362.6K5.06%346.61K--329.91K
Deferred tax -160.74%-22.07K-59.46%36.33K204.16%89.6K-5,072.76%-86.02K97.87%-1.66K---77.92K
Change In working capital 122.27%1.1M-2,349.91%-4.92M85.97%-200.81K-148.33%-1.43M8,597.76%2.96M---34.86K
-Change in receivables 158.21%2.27M-939.01%-3.91M-212.71%-376.08K-89.16%333.66K173.60%3.08M--1.12M
-Change in inventory 109.54%168.3K-94.84%80.32K408.38%1.56M-209.98%-504.39K133.45%458.61K---1.37M
-Change in prepaid assets 43.43%-770.93K-90.22%-1.36M-266.31%-716.36K154.36%430.74K-4,642.58%-792.44K---16.71K
-Change in payables and accrued expense -162.41%-260.66K161.06%417.66K26.92%-684.07K-117.80%-936.03K-233.18%-429.77K--322.7K
-Change in other current liabilities -72.13%-144.13K---83.73K--0--0--------
-Change in other working capital -168.72%-171.32K-414.77%-63.76K102.68%20.26K-216.60%-755.37K785.46%647.86K---94.51K
Cash from discontinued investing activities
Operating cash flow 340.50%2.9M-138.87%-1.21M96.53%3.11M-72.95%1.58M133.43%5.84M--2.5M
Investing cash flow
Cash flow from continuing investing activities -13.43%-10.79M-23.08%-9.51M-6,293.71%-7.73M88.68%-120.9K45.49%-1.07M-1.96M
Net PPE purchase and sale -4,484.59%-6.63M-39.31%-144.6K-158.43%-103.8K6.33%-40.17K69.83%-42.88K---142.11K
Net intangibles purchase and sale --0---979.28K--0--0--------
Net business purchase and sale ---500K--0--0------------
Net investment purchase and sale 56.35%-3.66M-10.01%-8.39M-1,613.17%-7.63M45.02%-445.17K-383.72%-809.73K--285.4K
Net other investing changes ------------269.48%364.43K89.77%-215.03K---2.1M
Cash from discontinued investing activities
Investing cash flow -13.43%-10.79M-23.08%-9.51M-6,293.71%-7.73M88.68%-120.9K45.49%-1.07M---1.96M
Financing cash flow
Cash flow from continuing financing activities -36.91%7.35M68.64%11.65M5,571.18%6.91M104.25%121.86K-734.59%-2.87M-343.91K
Net issuance payments of debt 10.55%7.59M61.42%6.87M--4.25M--0-678.54%-2.77M---355.32K
Net common stock issuance --0-96.10%312K--8M--0--0----
Proceeds from stock option exercised by employees --0--0--336.64K--0--0----
Net other financing activities -105.31%-237.88K178.80%4.48M-4,761.29%-5.68M217.30%121.86K-1,009.98%-103.88K--11.42K
Cash from discontinued financing activities
Financing cash flow -36.91%7.35M68.64%11.65M5,571.18%6.91M104.25%121.86K-734.59%-2.87M---343.91K
Net cash flow
Beginning cash position 17.41%8.14M44.59%6.93M30.51%4.79M120.75%3.67M-14.34%1.66M--1.94M
Current changes in cash -157.33%-534.91K-59.20%933.05K44.59%2.29M-16.99%1.58M849.08%1.91M--200.77K
Effect of exchange rate changes -151.03%-139.64K282.54%273.63K67.50%-149.9K-546.49%-461.24K121.56%103.3K---479.21K
End cash Position -8.29%7.46M17.41%8.14M44.59%6.93M30.51%4.79M120.75%3.67M--1.66M
Free cash flow -59.82%-3.73M-177.91%-2.33M94.25%2.99M-73.44%1.54M145.69%5.8M--2.36M
Currency Unit USDUSDUSDUSDUSDUSD
Audit Opinions Unqualified OpinionUnqualified Opinion with Explanatory NotesUnqualified OpinionUnqualified Opinion----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More